Coya Therapeutics, Inc. (COYA) Executive Compensation
Coya Therapeutics, Inc. (COYA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: COYA
CIK: 1835022
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weaver and Tidwell, L.L.P.
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerCarey Savio
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001193125-26-421066 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001193125-26-413218 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391378 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343481 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343473 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-07 | 2026-03-29 | 8-K/A | 0001193125-26-340449 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0001493152-26-034737 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-25 | 8-K | 0001193125-26-282989 | View SEC Doc Filr Page |
| ARS | 2026-05-13 | 2025-12-31 | ARS | 0001193125-26-220695 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-13 | — | DEFA14A | 0001193125-26-220690 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-13 | 2026-06-25 | DEF 14A | 0001193125-26-220688 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-218282 | View SEC Doc Filr Page |
| 424B5 | 2026-05-12 | — | 424B5 | 0001193125-26-218278 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-218201 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-218198 | View SEC Doc Filr Page |
| 4 | 2026-04-09 | 2026-04-09 | 4 | 0001193125-26-149968 | View SEC Doc Filr Page |
| 3 | 2026-04-09 | 2026-04-01 | 3 | 0001193125-26-149960 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-03-29 | 8-K | 0001193125-26-139094 | View SEC Doc Filr Page |
| EFFECT | 2026-03-20 | — | EFFECT Filing | 9999999995-26-000895 | View SEC Doc Filr Page |
| 424B3 | 2026-03-20 | — | 424B3 | 0001193125-26-117738 | View SEC Doc Filr Page |
| CORRESP | 2026-03-19 | — | CORRESP Filing | 0001193125-26-115931 | View SEC Doc Filr Page |
| UPLOAD | 2026-03-19 | — | UPLOAD Filing | 0000000000-26-002775 | View SEC Doc Filr Page |
| S-3 | 2026-03-16 | — | S-3 | 0001193125-26-107413 | View SEC Doc Filr Page |
| 10-K | 2026-03-16 | 2025-12-31 | 10-K | 0001193125-26-107281 | View SEC Doc Filr Page |
| 8-K | 2026-03-16 | 2026-03-16 | 8-K | 0001193125-26-107276 | View SEC Doc Filr Page |